Sign Up to like & get
recommendations!
0
Published in 2020 at "Journal of Liposome Research"
DOI: 10.1080/08982104.2020.1748648
Abstract: Abstract Temozolomide is a drug approved for treating glioblastomas, which has 100% oral bioavailability but gets degraded at physiological pH thus having very short half-life and only 20–30% brain bioavailability. Due to its amphiphilic nature,…
read more here.
Keywords:
drug loading;
entrapment efficiency;
lipid crystal;
crystal nanoparticles ... See more keywords